Beijing Longwood Valley Medical Technology Co., Ltd. - 北京长木谷医疗科技股份有限公司
Beijing developer of ROPA, an NMPA-approved AI orthopedic surgical robot for hip and knee replacement.
Beijing Longwood Valley Medical Technology Co., Ltd., operating under the brand Changmugu, is a Chinese orthopedic AI and surgical robotics company founded on April 17, 2018 and led by CEO Dr. Zhang Yiling. The company is headquartered in the Beijing Economic-Technological Development Area in Tongzhou District, Beijing, with registered capital of RMB 30 million, and holds Class II and Class III medical device production and operation licenses. Changmugu has been recognized as a National High-tech Enterprise and as a national-level 'little giant' (specialized, refined, differentiated and innovative) enterprise for its work applying artificial intelligence to orthopedic surgery.
The company's core technology combines AI deep learning, 3D printing and surgical navigation to support pre-operative planning and intra-operative guidance for joint replacement surgery. Its AIJOINT AI surgical simulation and planning software, covering hip and knee applications marketed as AIHIP and AIKNEE, received what the company describes as China's first Class III innovative medical device certificate for an AI-plus-orthopedic-treatment product. In October 2024, Changmugu's ROPA orthopedic surgical robot received NMPA approval, which the company and Chinese media described as the world's first AI-plus-robot orthopedic surgical robot to reach the market, combining the AI planning software with a robotic arm for precision guidance during total hip and knee replacement procedures.
Changmugu has raised institutional financing to support its R&D and regulatory work, including an early Series A round of several tens of millions of RMB around 2020 and a Series B round of RMB 540 million completed around 2021, with investors reported to include CICC Capital, IDG Capital and CDH's VGC fund, and CEC Capital Group serving as exclusive financial advisor on the B round. The company has also established a strategic partnership with Johnson & Johnson Medical focused on orthopedic joint digitization and AI-assisted 3D precision diagnosis and treatment in China.
Through its combination of AI planning software and the NMPA-approved ROPA robotic platform, Changmugu positions itself as a domestic alternative to imported orthopedic surgical robots, targeting hospital joint replacement departments across China.
Primary type & automation activities this supplier delivers:
ROPA
- Launch Year: 2024
NMPA-approved AI orthopedic surgical robot combining a robotic arm with AI planning for hip and knee replacement.
AIJOINT
AI surgical simulation and planning software for joint replacement, covering hip (AIHIP) and knee (AIKNEE) applications.
Contact Beijing Longwood Valley Medical Technology Co., Ltd.
WEBSITE
https://changmugu.com/HEADQUARTERS
China
Company Facts
Founded
2018
Primary Role
Manufacturer
Company Size
-
Primary Region
Asia-Pacific
Annual Sales
-
Funding Stage
Growth / Late-Stage VC
Funding Total
-
Certifications & Memberships
WRC 2026 Exhibitor Map: 248 Robotics Companies Mapped
We classified 248 WRC 2026 exhibitors with the RobotToday taxonomy. Humanoid leads at 77 companies; the chain narrows to 11 in compute and 2 in power.
ROBOTTODAY WEEKLY August 17 – 21, 2026
This week in robotics: Unitree surges 629% in its Shanghai STAR Market debut at a $66 billion valuation, Nevada approves 7,000 robotaxis, Amazon Prime Air expands to nearly 500 US cities, and Beijing's World Robot Conference marks the industry's pivot from spectacle to scale. August 17–21, 2026.
World Robot Conference 2026 Opens in Beijing Aug. 19–23, Days After Unitree's $9B IPO
WRC 2026 opens August 19 in Beijing with 300+ exhibitors, a first-ever SOE pavilion and a new Procurement Day, days after Unitree priced China's first mainland-listed humanoid robot IPO at a $9.04 billion valuation.
ROBOTTODAY Weekly July 27 – 31, 2026
Your weekly robotics briefing: the US bans imports of Chinese humanoid robots, Google DeepMind unveils Gemini Robotics 2, Unitree pushes toward its Shanghai IPO, and Amazon's Zoox wins approval for paid robotaxi rides.
FCC Robot Ban Takes Effect, Unitree Launches $620M IPO
The FCC's Covered List robot ban and a House-passed NDAA provision land within days of each other, while Unitree launches its $620M STAR Market IPO. A supply-chain and market-access update.
ROBOTTODAY Weekly July 20 – 24, 2026
Your weekly robotics briefing: AGIBOT unveils four new robots at WAIC 2026, the NDAA bars Chinese humanoids from the U.S. military, SoftBank eyes Gravis Robotics for its Roze vehicle, and Anduril reveals its Thunder autonomous attack tiltrotor at Farnborough.
US Restrictions on Chinese Humanoid Robots: The Full Map
Every US restriction on Chinese humanoid robots — NDAA Sec. 163, GUARD Act, the 1260H list — plus the supply-chain math and a 4-tier map of decoupling.
AI for Science 2026: The Global Race for Scientific Discovery
2026 AI for Science landscape report: WAIC 2026 exhibitor breakdown, MIT Boltz-2 and CMU Coscientist case studies, US/China/EU policy comparison, Anthropic Claude Science, and US academic cautionary views.
2026H2 Robotics Events Briefing: Tailored Recommendations for Robotics Readers
Discover the ultimate directory of global robotics events in 2026. Tailored briefings for engineers, investors, and founders on humanoid robots, AI, and industrial automation by RobotToday.
World Humanoid Robot Games 2026 | Aug 22–26, Beijing | 2nd Edition
The 2nd World Humanoid Robot Games takes place August 22–26, 2026 at Beijing's National Speed Skating Oval. 32 events, 500+ humanoid robots, fully autonomous 100m sprint and real-world scenario tasks — the world's only Olympics for humanoid robots.
